Form 8-K12B
Wave Life Sciences, Inc., 8-K12B filed 2026-08-07
The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.
Filing record
8-K12B filed with the Securities and Exchange Commission by Wave Life Sciences, Inc. (CIK 0001631574) on 2026-08-07.
Accession number 0001193125-26-340430. EDGAR reports the filing package as 972 KB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/1631574/000119312526340430/0001193125-26-340430-index.htm.
Items reported on the cover
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits